DoW Bone Marrow Failure, Investigator-Initiated Research Award
Funds research to advance mature ideas or key discoveries in bone marrow failure, supporting translational and clinical studies (but not clinical trials) and allowing for collaborative investigator teams.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 5, 2026: Pre-application | November 4, 2026: Full application | November 12, 2026: End of verification period
Funding Amounts: Up to $1.25M total costs per award (max 3 years); typically 1 award expected.
Summary: Supports translational and clinical research (excluding clinical trials) to advance understanding, prevention, and treatment of bone marrow failure diseases.
Key Information: Requires pre-application and invitation to submit full application; preliminary data are mandatory; no clinical trials allowed.
Description
This opportunity supports investigator-initiated research projects that advance the understanding, prevention, and treatment of inherited or acquired bone marrow failure (BMF) diseases. Projects may involve translational and clinical research, including preclinical models, human data, anatomical substances, and correlative studies associated with clinical trials (but not clinical trials themselves). The award aims to fund impactful research that addresses critical gaps in BMF disease research or patient care, with an emphasis on mature ideas and preliminary data. The program encourages multidisciplinary collaborations and offers a partnering Principal Investigator (PI) option.
